{"id":420,"date":"2019-12-01T20:17:10","date_gmt":"2019-12-02T01:17:10","guid":{"rendered":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/10-5-analgesic-and-musculoskeletal-medications\/"},"modified":"2022-01-20T21:21:52","modified_gmt":"2022-01-21T02:21:52","slug":"10-5-pain-and-mobility-medications-overview","status":"publish","type":"chapter","link":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/10-5-pain-and-mobility-medications-overview\/","title":{"raw":"10.5 Pain and Mobility Medications Overview","rendered":"10.5 Pain and Mobility Medications Overview"},"content":{"raw":"<div class=\"1.5-analgesic-and-musculoskeletal-medications\">\r\n\r\nAnalgesics used to treat pain are categorized as non-opioid, opioid, and adjuvant medications. Non-opioid medications include acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs).<i> <\/i><strong style=\"text-align: initial;font-size: 14pt\">[pb_glossary id=\"675\"]Adjuvant analgesics [\/pb_glossary]<\/strong><span style=\"text-align: initial;font-size: 14pt\"> are defined as drugs with a primary indication other than pain that have analgesic properties in some painful conditions. This group includes numerous drugs in diverse classes such as gabapentin (an anticonvulsant), amitriptyline (a tricyclic antidepressant), or muscle relaxants.<\/span><sup style=\"text-align: initial\">[footnote]Lussier, D., Huskey, A., &amp; Portenoy, R. (2004).\u00a0 Adjuvant analgesics in cancer pain management. <em>Oncologist, 9<\/em>(5); 571-91.\u00a0 <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15477643\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15477643<\/a>.[\/footnote]<\/sup><span style=\"text-align: initial;font-size: 14pt\"> Each of these classes will be discussed in more detail along with antigout medications and a brief overview of anesthetic medication.<\/span>\r\n\r\n<\/div>\r\n<div class=\"1.5-analgesic-and-musculoskeletal-medications\">\r\n<h2>Analgesic and Musculoskeletal Medication Classifications<\/h2>\r\nThe next sections will introduce different classes of analgesics and musculoskeletal medications with specific administration considerations, therapeutic effects, adverse\/side effects, and teaching needed for each class of medications.\r\n\r\nAnalgesic and musculoskeletal medications are available in many different forms, such as oral tablets, oral liquids, injections, inhalation, and transdermal. Some products contain more than one medicine (for example, oxycodone and acetaminophen) to enhance pain relief.\r\n\r\n<\/div>","rendered":"<div class=\"1.5-analgesic-and-musculoskeletal-medications\">\n<p>Analgesics used to treat pain are categorized as non-opioid, opioid, and adjuvant medications. Non-opioid medications include acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs).<i> <\/i><strong style=\"text-align: initial;font-size: 14pt\">Adjuvant analgesics <\/strong><span style=\"text-align: initial;font-size: 14pt\"> are defined as drugs with a primary indication other than pain that have analgesic properties in some painful conditions. This group includes numerous drugs in diverse classes such as gabapentin (an anticonvulsant), amitriptyline (a tricyclic antidepressant), or muscle relaxants.<\/span><sup style=\"text-align: initial\"><a class=\"footnote\" title=\"Lussier, D., Huskey, A., &amp; Portenoy, R. (2004).\u00a0 Adjuvant analgesics in cancer pain management. Oncologist, 9(5); 571-91.\u00a0 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15477643.\" id=\"return-footnote-420-1\" href=\"#footnote-420-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/sup><span style=\"text-align: initial;font-size: 14pt\"> Each of these classes will be discussed in more detail along with antigout medications and a brief overview of anesthetic medication.<\/span><\/p>\n<\/div>\n<div class=\"1.5-analgesic-and-musculoskeletal-medications\">\n<h2>Analgesic and Musculoskeletal Medication Classifications<\/h2>\n<p>The next sections will introduce different classes of analgesics and musculoskeletal medications with specific administration considerations, therapeutic effects, adverse\/side effects, and teaching needed for each class of medications.<\/p>\n<p>Analgesic and musculoskeletal medications are available in many different forms, such as oral tablets, oral liquids, injections, inhalation, and transdermal. Some products contain more than one medicine (for example, oxycodone and acetaminophen) to enhance pain relief.<\/p>\n<\/div>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-420-1\">Lussier, D., Huskey, A., &amp; Portenoy, R. (2004).\u00a0 Adjuvant analgesics in cancer pain management. <em>Oncologist, 9<\/em>(5); 571-91.\u00a0 <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15477643\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15477643<\/a>. <a href=\"#return-footnote-420-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><\/ol><\/div><div class=\"glossary\"><span class=\"screen-reader-text\" id=\"definition\">definition<\/span><template id=\"term_420_675\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_420_675\"><div tabindex=\"-1\"><\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><\/div>","protected":false},"author":103,"menu_order":5,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":["open-resources-for-nursing-open-rn"],"pb_section_license":""},"chapter-type":[48],"contributor":[68],"license":[],"class_list":["post-420","chapter","type-chapter","status-publish","hentry","chapter-type-numberless","contributor-open-resources-for-nursing-open-rn"],"part":405,"_links":{"self":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/420","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/103"}],"version-history":[{"count":9,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/420\/revisions"}],"predecessor-version":[{"id":2295,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/420\/revisions\/2295"}],"part":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/405"}],"metadata":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/420\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=420"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=420"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=420"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}